These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18661519)

  • 1. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
    He W; Kularatne SA; Kalli KR; Prendergast FG; Amato RJ; Klee GG; Hartmann LC; Low PS
    Int J Cancer; 2008 Oct; 123(8):1968-73. PubMed ID: 18661519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry.
    He W; Wang H; Hartmann LC; Cheng JX; Low PS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11760-5. PubMed ID: 17601776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
    Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
    Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.
    Fan T; Zhao Q; Chen JJ; Chen WT; Pearl ML
    Gynecol Oncol; 2009 Jan; 112(1):185-91. PubMed ID: 18954898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status.
    Moreno JG; O'Hara SM; Gross S; Doyle G; Fritsche H; Gomella LG; Terstappen LW
    Urology; 2001 Sep; 58(3):386-92. PubMed ID: 11549486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
    Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
    Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
    Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
    Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.
    Shao C; Liao CP; Hu P; Chu CY; Zhang L; Bui MH; Ng CS; Josephson DY; Knudsen B; Tighiouart M; Kim HL; Zhau HE; Chung LW; Wang R; Posadas EM
    PLoS One; 2014; 9(2):e88967. PubMed ID: 24551200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
    Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
    Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.
    Meyer CP; Pantel K; Tennstedt P; Stroelin P; Schlomm T; Heinzer H; Riethdorf S; Steuber T
    Urol Oncol; 2016 May; 34(5):235.e11-6. PubMed ID: 26795608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.
    Lee M; Kim EJ; Cho Y; Kim S; Chung HH; Park NH; Song YS
    Gynecol Oncol; 2017 May; 145(2):361-365. PubMed ID: 28274569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer.
    Poveda A; Kaye SB; McCormack R; Wang S; Parekh T; Ricci D; Lebedinsky CA; Tercero JC; Zintl P; Monk BJ
    Gynecol Oncol; 2011 Sep; 122(3):567-72. PubMed ID: 21664658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells.
    Balasubramanian P; Yang L; Lang JC; Jatana KR; Schuller D; Agrawal A; Zborowski M; Chalmers JJ
    Mol Pharm; 2009; 6(5):1402-8. PubMed ID: 19445481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nondestructive capture, release, and detection of circulating tumor cells with cystamine-mediated folic acid decorated magnetic nanospheres.
    Li F; Wang M; Cai H; He Y; Xu H; Liu Y; Zhao Y
    J Mater Chem B; 2020 Nov; 8(43):9971-9979. PubMed ID: 33174893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope.
    Ntouroupi TG; Ashraf SQ; McGregor SB; Turney BW; Seppo A; Kim Y; Wang X; Kilpatrick MW; Tsipouras P; Tafas T; Bodmer WF
    Br J Cancer; 2008 Sep; 99(5):789-95. PubMed ID: 18682708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic Acid-Modified Fluorescent-Magnetic Nanoparticles for Efficient Isolation and Identification of Circulating Tumor Cells in Ovarian Cancer.
    Pan Y; Wang Z; Ma J; Zhou T; Wu Z; Ding P; Sun N; Liu L; Pei R; Zhu W
    Biosensors (Basel); 2022 Mar; 12(3):. PubMed ID: 35323454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
    Ali A; Furusato B; Ts'o PO; Lum ZP; Elsamanoudi S; Mohamed A; Srivastava S; Moul JW; Brassell SA; Sesterhenn IA; McLeod DG
    Pathol Int; 2010 Oct; 60(10):667-72. PubMed ID: 20846264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.